# Using Yeast Cell Walls to Deliver Genetic Medicine

> A method for using hollowed-out yeast cell walls as tiny transport containers to deliver genetic payloads like DNA or RNA into cells.

- **Patent:** US 8580275
- **Original title:** Drug delivery product and methods
- **Owner:** University of Massachusetts Amherst
- **Granted:** 2013
- **Status:** Active
- **Times cited:** 4
- **Field:** biotech, pharmaceutical

## What it does

This patent describes a biological delivery system that uses the empty shell of a yeast cell as a protective vessel. To keep a genetic payload—like siRNA or DNA—inside this shell, the inventors add a cationic (positively charged) trapping molecule. Because genetic material is typically negatively charged, the positive 'trapping' molecule acts like a magnet, holding the medicine securely inside the yeast shell until it reaches its target. This allows the system to carry delicate therapeutic molecules through the body without them breaking down prematurely.

## What it does NOT cover

- Does not cover delivery systems that use synthetic or non-yeast-based shells.
- Does not cover systems that lack a cationic trapping molecule to secure the payload.
- Does not cover the use of yeast cell walls that contain more than 90 weight percent beta-glucan.
- Does not cover payloads that are not nucleic acids, such as small molecule drugs or proteins, unless they are specifically part of a nucleic acid construct.

## The clever bit

The invention uses the natural, porous structure of a yeast cell wall as a physical cage, combined with electrostatic attraction (positive trapping molecule to negative DNA/RNA) to prevent the payload from leaking out.

## Real-world examples

1. Targeted gene therapy research
2. Oral delivery of RNA-based therapeutics
3. Vaccine delivery platforms

## Why it matters

Delivering genetic medicine is notoriously difficult because the body often destroys DNA or RNA before it reaches the target. By repurposing natural yeast cell walls, this technology provides a biodegradable and potentially non-toxic way to package these sensitive therapies, which is a major hurdle in gene therapy and vaccine development.

## Frequently asked questions

### What does Using Yeast Cell Walls to Deliver Genetic Medicine cover?

A method for using hollowed-out yeast cell walls as tiny transport containers to deliver genetic payloads like DNA or RNA into cells.

### Who owns patent US 8580275?

University of Massachusetts Amherst owns this patent, granted in 2013.

### When does this patent expire?

This patent is expected to expire on November 12, 2033, when the invention enters the public domain.

### What is patent US 8580275 cited by?

This patent has been cited by 4 later patents that build on its ideas.

### What problem does this patent solve?

Delivering genetic medicine is notoriously difficult because the body often destroys DNA or RNA before it reaches the target. By repurposing natural yeast cell walls, this technology provides a biodegradable and potentially non-toxic way to package these sensitive therapies, which is a major hurdle in gene therapy and vaccine development.

### What does this patent NOT cover?

Does not cover delivery systems that use synthetic or non-yeast-based shells.

**Full plain-English explainer:** https://patentbrief.org/patent/us/8580275/car-t-cell-therapy

**Original patent:** https://patents.google.com/patent/US8580275

---

_Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._